Pneumomediastinum and Pneumopericardium in Rapidly Progressive Interstitial Lung Disease Secondary to Anti‐MDA5 Dermatomyositis [PDF]
Clinical Case ReportsAnti‐melanoma differentiation associated protein 5 antibody positive dermatomyositis (anti‐MDA5 dermatomyositis) is characterized by rapidly progressive interstitial lung disease and skin involvement with a paucity of muscle involvement.
Thomas Bond +3 more
doaj +2 more sources
Amyopathic Dermatomyositis in a Patient With Breast Cancer in Remission: A Case Report and a Systematic Review of the Literature [PDF]
Case Reports in Dermatological MedicineAmyopathic dermatomyositis is a rare inflammatory disease in the spectrum of dermatomyositis characterized by typical skin lesions in the absence of muscle involvement. Dermatomyositis is a well-known paraneoplastic syndrome that can reveal or indicate a
Rym Afiouni +4 more
doaj +2 more sources
Acta Dermato-Venereologica, 2018 Anti-transcriptional intermediary factor-1γ (TIF-1γ) autoantibody may be associated with cancer in adult patients with dermatomyositis. The aim of this study was to evaluate the risk of cancer in the presence of anti-TIF-1γ autoantibody in adult ...
Marion Best +5 more
doaj +2 more sources
Research progress on risk factors for dermatomyositis with malignancy
Pifu-xingbing zhenliaoxue zazhi, 2023 Malignant tumors are one of the major causes of mortality in patients with dermatomyositis. But the majority of these tumors are diagnosed after the diagnosis of dermatomyositis. Because the timing of diagnosis of tumor is associated with the survival of
Juanjuan PAN, Jing WANG, Guozhen TAN
doaj +1 more source
Trial of Intravenous Immune Globulin in Dermatomyositis.
New England Journal of Medicine, 2022 BACKGROUND Intravenous immune globulin (IVIG) for the treatment of dermatomyositis has not been extensively evaluated. METHODS We conducted a randomized, placebo-controlled trial involving patients with active dermatomyositis.
R. Aggarwal +29 more
semanticscholar +1 more source
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Frontiers in Immunology, 2021 Anti-MDA5 dermatomyositis is a rare systemic autoimmune disease, historically described in Japanese patients with clinically amyopathic dermatomyositis and life-threatening rapidly progressive interstitial lung disease.
Anaïs Nombel, N. Fabien, F. Coutant
semanticscholar +1 more source
Paraneoplastic Wong-Type Dermatomyositis Associated with Gynecological Malignancy
Medicina, 2022 Although dermatomyositis is known to be a possible paraneoplastic syndrome, often in the setting of gynecological cancers, Wong-type dermatomyositis—a rare variant of dermatomyositis—has not been clearly associated with internal malignancies to date ...
Roberto Russo +4 more
doaj +1 more source
Autoantibody Markers of Increased Risk of Malignancy in Patients with Dermatomyositis
Clinical reviews in allergy and immunology, 2022 Dermatomyositis is a chronic inflammatory disease involving the skin and muscles. It most commonly occurs in adults with preponderance in females, but pediatric occurrence is also possible.
Milena Marzęcka +2 more
semanticscholar +1 more source
New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review
Rheumatology International, 2022 Dermatomyositis is a rare, type I interferon-driven autoimmune disease, which can affect muscle, skin and internal organs (especially the pulmonary system).
M. Holzer +6 more
semanticscholar +1 more source
Incidence, Prevalence, and Mortality of Dermatomyositis: A Population‐Based Cohort Study
Arthritis care & research, 2021 We aimed to determine the population‐based incidence, prevalence, and mortality of dermatomyositis (DM) using European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) criteria.
V. Kronzer +5 more
semanticscholar +1 more source